1. Home
  2. NGNE vs MOMO Comparison

NGNE vs MOMO Comparison

Compare NGNE & MOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurogene Inc.

NGNE

Neurogene Inc.

HOLD

Current Price

$30.98

Market Cap

744.9M

Sector

Health Care

ML Signal

HOLD

Logo Hello Group Inc.

MOMO

Hello Group Inc.

HOLD

Current Price

$4.98

Market Cap

882.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NGNE
MOMO
Founded
2003
2011
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
744.9M
882.1M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
NGNE
MOMO
Price
$30.98
$4.98
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$63.57
N/A
AVG Volume (30 Days)
234.1K
817.1K
Earning Date
05-08-2026
06-04-2026
Dividend Yield
N/A
4.61%
EPS Growth
0.93
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.68
P/E Ratio
N/A
$10.60
Revenue Growth
N/A
N/A
52 Week Low
$15.93
$4.86
52 Week High
$43.66
$7.70

Technical Indicators

Market Signals
Indicator
NGNE
MOMO
Relative Strength Index (RSI) 41.25 34.16
Support Level $31.20 N/A
Resistance Level $33.99 $6.52
Average True Range (ATR) 1.95 0.16
MACD -0.47 0.00
Stochastic Oscillator 20.29 18.05

Price Performance

Historical Comparison
NGNE
MOMO

About NGNE Neurogene Inc.

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACT(Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.

About MOMO Hello Group Inc.

Hello Group Inc is a foremost player in Asia's online social networking space. Through Momo, Tantan and other properties within its product portfolio, It enable users to discover new relationships, expand their social connections and build meaningful interactions. Momo is a mobile application that connects people and facilitates social interactions based on location, interests and a variety of online recreational activities. Tantan, which it added to its family of applications through acquisition. Tantan is designed to help its users find and establish romantic connections as well as meet interesting people. The Group determined that it operated in three operating segments namely Momo, Tantan and QOOL. The majority of revenue comes from Chinese mainland as compare to Overseas.

Share on Social Networks: